PNC Financial Services Group Inc. Sells 186 Shares of Amedisys, Inc. (NASDAQ:AMED)

PNC Financial Services Group Inc. lessened its holdings in Amedisys, Inc. (NASDAQ:AMED) by 2.8% in the fourth quarter, HoldingsChannel reports. The fund owned 6,486 shares of the health services provider’s stock after selling 186 shares during the period. PNC Financial Services Group Inc.’s holdings in Amedisys were worth $617,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. Retirement Systems of Alabama boosted its position in shares of Amedisys by 0.3% in the fourth quarter. Retirement Systems of Alabama now owns 40,871 shares of the health services provider’s stock valued at $3,885,000 after acquiring an additional 125 shares during the period. Treasurer of the State of North Carolina boosted its position in shares of Amedisys by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 14,204 shares of the health services provider’s stock valued at $1,350,000 after acquiring an additional 140 shares during the period. Mesirow Institutional Investment Management Inc. boosted its position in shares of Amedisys by 9.9% in the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 2,844 shares of the health services provider’s stock valued at $270,000 after acquiring an additional 257 shares during the period. Paralel Advisors LLC boosted its position in shares of Amedisys by 1.1% in the third quarter. Paralel Advisors LLC now owns 26,002 shares of the health services provider’s stock valued at $2,429,000 after acquiring an additional 295 shares during the period. Finally, Xponance Inc. lifted its position in Amedisys by 9.3% during the fourth quarter. Xponance Inc. now owns 4,454 shares of the health services provider’s stock worth $423,000 after purchasing an additional 378 shares during the period. Institutional investors own 94.36% of the company’s stock.

Amedisys Stock Down 0.1 %

AMED stock opened at $92.00 on Thursday. The stock has a market capitalization of $3.01 billion, a P/E ratio of -143.75, a price-to-earnings-growth ratio of 2.26 and a beta of 0.80. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. Amedisys, Inc. has a 12 month low of $89.55 and a 12 month high of $97.36. The firm has a 50-day moving average price of $93.01 and a 200-day moving average price of $93.47.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01. The firm had revenue of $571.41 million during the quarter, compared to analysts’ expectations of $565.38 million. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.00 earnings per share. As a group, equities research analysts anticipate that Amedisys, Inc. will post 4.57 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on AMED shares. StockNews.com raised shares of Amedisys from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research report on Tuesday, March 26th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a research report on Thursday, April 25th. Finally, Royal Bank of Canada upped their price objective on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, March 25th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Amedisys currently has an average rating of “Hold” and an average price target of $100.80.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.